XOMA Royalty Corp. (XOMA)
26.73
-0.19
(-0.71%)
USD |
NASDAQ |
Jan 23, 16:00
26.73
0.00 (0.00%)
After-Hours: 20:00
XOMA Royalty Research and Development Expense (TTM): 2.295M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Mirum Pharmaceuticals, Inc. | 178.77M |
| Recursion Pharmaceuticals, Inc. | 433.37M |
| Rezolute, Inc. | 61.92M |
| Vistagen Therapeutics, Inc. | 49.02M |
| Zevra Therapeutics, Inc. | 16.83M |